Background Background Increasing attention has
Increasing attention has been given by researchers to cannabis use been given by researchers to cannabis use in individuals with psychosis. As psychoses in individuals with psychosis. As psychoses are relatively low-prevalence disorders, are relatively low-prevalence disorders, research has been mostly been restricted research has been mostly been restricted to small-scale studies of treatment to small-scale studies of treatment samples.The reported prevalence samples.The reported prevalence estimates obtained from these studies estimates obtained from these studies vary widely. vary widely.
Aims Aims To provide prevalence estimates
To provide prevalence estimates based on larger samples and to examine based on larger samples and to examine sources of variability in prevalence sources of variability in prevalence estimates across studies. estimates across studies.
Method Method Data from 53 studies of
Data from 53 studies of treatment samples and 5 epidemiological treatment samples and 5 epidemiological studies were analysed. studies were analysed.
Results

Results Based on treatment sample
Based on treatment sample data, prevalence estimates were data, prevalence estimates were calculated forcurrentuse (23.0%), current calculated forcurrentuse (23.0%), current misuse (11.3%),12-month use (29.2%),12-misuse (11.3%),12-month use (29.2%),12-month misuse (18.8%), lifetime use (42.1%) month misuse (18.8%), lifetime use (42.1%) and lifetime misuse (22.5%). and lifetime misuse (22.5%). Epidemiological studies consistently Epidemiological studies consistently reported higher cannabis use and misuse reported higher cannabis use and misuse prevalence in people with psychosis. prevalence in people with psychosis.
Conclusions Conclusions The factor most
The factor most consistently associated with increased consistently associated with increased odds of cannabis prevalence was odds of cannabis prevalence was specificity of diagnosis. Factors such as specificity of diagnosis.Factors such as consumption patterns and study design consumption patterns and study design merit further consideration. merit further consideration.
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Substance use is widespread in the Substance use is widespread in the community (Costa e Silva, 2002) . Cannabis community (Costa e Silva, 2002 Os et al et al (2002) and Zammit (2002) and Zammit et al et al (2002) have reported an association be- (2002) have reported an association between cannabis use and later psychosis. tween cannabis use and later psychosis. However, sharp increases in cannabis use However, sharp increases in cannabis use have not been reflected in an increased have not been reflected in an increased prevalence of schizophrenia (Degenhardt prevalence of schizophrenia (Degenhardt et al et al, 2003) . Also, a notable feature of the , 2003). Also, a notable feature of the available literature has been the conflicting available literature has been the conflicting findings on the prevalence of substance use findings on the prevalence of substance use and associated outcomes on psychosis and associated outcomes on psychosis (Rabinowitz (Rabinowitz et al et al, 1998) . The conflicting , 1998). The conflicting results have been attributed to factors such results have been attributed to factors such as sample composition (Mueser as sample composition (Mueser et al et al, 1990; , 1990; Blanchard Blanchard et al et al, 2000) , country (Ham-, 2000) , country (Hambrecht & Hafner, 1996) , recruitment brecht & Hä fner, 1996), recruitment source (Mueser source (Mueser et al et al, 1990; Hambrecht & , 1990; Hambrecht & Hafner, 1996; Fowler Hä fner, 1996; Fowler et al et al, 1998) and , 1998 ) and issues associated with diagnosis and method issues associated with diagnosis and method of data collection (Mueser of data collection (Mueser et al et al, 1990; , 1990; Hambrecht & Hafner, 1996; Fowler Hambrecht & Hä fner, 1996; Fowler et al et al, , 1998; Blanchard 1998; Blanchard et al et al, 2000) . However, , 2000) . However, little research has been undertaken into faclittle research has been undertaken into factors contributing to the variability in prevtors contributing to the variability in prevalence estimates. The aim of our review is alence estimates. The aim of our review is to obtain more reliable estimates of the to obtain more reliable estimates of the prevalence of cannabis use based on larger prevalence of cannabis use based on larger samples, to examine factors that may be samples, to examine factors that may be associated with variability in prevalence associated with variability in prevalence estimates and to compare prevalence estiestimates and to compare prevalence estimates of individuals with and without mates of individuals with and without psychosis. psychosis.
METHOD METHOD
We examined reports of cannabis use and We examined reports of cannabis use and misuse prevalence, and whether the variamisuse prevalence, and whether the variability in these prevalence estimates was bility in these prevalence estimates was associated with factors identified by the associated with factors identified by the researchers as potentially important. These researchers as potentially important. These factors included age and percentage of factors included age and percentage of males in studies, median year of data collecmales in studies, median year of data collection, geographic area, recruitment source, tion, geographic area, recruitment source, first-episode status, specificity of diagnosis first-episode status, specificity of diagnosis of psychosis and use of standard diagnostic of psychosis and use of standard diagnostic classification criteria. classification criteria.
Inclusion criteria Inclusion criteria
Citations and academic databases were Citations and academic databases were searched to identify English-language searched to identify English-language studies published between 1990 and 2002 studies published between 1990 and 2002 which might contain data on the use or miswhich might contain data on the use or misuse of cannabis by people diagnosed with use of cannabis by people diagnosed with psychosis, schizophrenia-spectrum dispsychosis, schizophrenia-spectrum disorders or schizophrenia. Search terms used orders or schizophrenia. Search terms used in PsycInfo and Medline were CANNABIS, in PsycInfo and Medline were CANNABIS, MARIHUANA, MARIJUANA MARIHUANA, MARIJUANA or or HASH-HASH-ISH combined with SCHIZOPHRENIA, ISH combined with SCHIZOPHRENIA, PSYCHOSIS PSYCHOSIS or or PSYCHOTIC. A second PSYCHOTIC. A second search was conducted using the term DUAL search was conducted using the term DUAL DIAGNOSIS. Where possible the authors DIAGNOSIS. Where possible the authors of studies were contacted to identify of studies were contacted to identify whether specific information on cannabis whether specific information on cannabis and psychosis or schizophrenia was availand psychosis or schizophrenia was available. We identified 164 clinical studies that able. We identified 164 clinical studies that might have contained information on might have contained information on cannabis use and psychosis. The following cannabis use and psychosis. The following review is based on 53 studies that met the review is based on 53 studies that met the inclusion criteria. In addition, five epiinclusion criteria. In addition, five epidemiological studies that met the inclusion demiological studies that met the inclusion criteria were analysed separately. criteria were analysed separately.
In-patient and community patient In-patient and community patient studies were included if the prevalence of studies were included if the prevalence of cannabis use or misuse among patients with cannabis use or misuse among patients with psychosis, schizophrenia-spectrum dispsychosis, schizophrenia-spectrum disorders or schizophrenia could be calculated orders or schizophrenia could be calculated (e.g. studies were excluded if there was no (e.g. studies were excluded if there was no breakdown by diagnosis or it was not clear breakdown by diagnosis or it was not clear whether all patients had psychotic sympwhether all patients had psychotic symptoms); information was available regarding toms); information was available regarding the prevalence interval used; substance use the prevalence interval used; substance use was not an inclusion criterion; the study was not an inclusion criterion; the study did not oversample by age, gender or other did not oversample by age, gender or other criteria; and patients were only included criteria; and patients were only included once. Research on the same sample was once. Research on the same sample was not included twice for the same prevalence not included twice for the same prevalence interval. Where a study reported prevalence interval. Where a study reported prevalence by psychosis in general, as well as by subby psychosis in general, as well as by subgroups such as schizophrenia, the more groups such as schizophrenia, the more specific information was selected. specific information was selected.
For the purpose of this review, misuse For the purpose of this review, misuse (including dependence) was the focus, since (including dependence) was the focus, since specific dependence data were not frespecific dependence data were not frequently reported. One study (Duke quently reported. One study (Duke et al et al, , 2001) reporting misuse was included with 2001) reporting misuse was included with the studies reporting use, since 'misuse' the studies reporting use, since 'misuse' was defined as 'any use'. Three time interwas defined as 'any use'. Three time intervals for reporting prevalence of cannabis vals for reporting prevalence of cannabis 3 0 6 3 0 6 Cannabis use and misuse prevalence among people  Cannabis use and misuse prevalence among people   with psychosis  with psychosis   BOB GREEN, ROSS YOUNG and DAVID KAVANAGH  BOB GREEN, ROSS YOUNG and DAVID KAVANAGH use and misuse were examined. Studies that use and misuse were examined. Studies that reported prevalence in terms of use or misreported prevalence in terms of use or misuse at a baseline assessment or in a 6-month use at a baseline assessment or in a 6-month period were categorised as current use or period were categorised as current use or misuse. Studies that reported prevalence in misuse. Studies that reported prevalence in terms of a 12-month to 18-month period terms of a 12-month to 18-month period were categorised as 12-month prevalence were categorised as 12-month prevalence studies, whereas studies reporting any use studies, whereas studies reporting any use or misuse ever were categorised as lifetime or misuse ever were categorised as lifetime studies. studies.
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Analysis Analysis
Three sets of analyses were conducted. The Three sets of analyses were conducted. The first analysis involved the calculation of first analysis involved the calculation of current, 12-month and lifetime prevalence current, 12-month and lifetime prevalence estimates. For each prevalence interval estimates. For each prevalence interval (e.g. current use), the total number of re-(e.g. current use), the total number of reported cannabis users in studies that conported cannabis users in studies that contained current use data was divided by the tained current use data was divided by the total sample size of the respective studies total sample size of the respective studies to calculate a weighted average. to calculate a weighted average. To examine potential sources of variaTo examine potential sources of variability in prevalence estimates, four multibility in prevalence estimates, four multivariate analyses were performed. The variate analyses were performed. The respective prevalence interval (e.g. lifetime respective prevalence interval (e.g. lifetime misuse) was the dependent variable and misuse) was the dependent variable and the following variables were entered as the following variables were entered as independent variables: recruitment source independent variables: recruitment source (whether study participants were recruited (whether study participants were recruited from a hospital, community setting or a from a hospital, community setting or a combination of both); geographic area combination of both); geographic area (studies were grouped as being conducted (studies were grouped as being conducted in either Australasia, continental Europe, in either Australasia, continental Europe, North America or the UK); use of standardNorth America or the UK); use of standardised substance misuse classification criteria ised substance misuse classification criteria (criteria reflecting an ICD or DSM diag-(criteria reflecting an ICD or DSM diagnosis, as opposed to criteria devised by nosis, as opposed to criteria devised by study authors); specificity of the diagnosis study authors); specificity of the diagnosis of psychosis (psychosis, schizophreniaof psychosis (psychosis, schizophreniaspectrum disorders or schizophrenia only) spectrum disorders or schizophrenia only) and first-episode status (a specific firstand first-episode status (a specific firstepisode sample or not). Average age of the episode sample or not). Average age of the study samples, percentage of males in a study samples, percentage of males in a study and the median year of data study and the median year of data collection for each study were covariates. collection for each study were covariates. Missing values for average age and percenMissing values for average age and percentage of males resulted in some studies not tage of males resulted in some studies not being included in the multivariate analyses being included in the multivariate analyses (Table 1) . Multinomial logistic regression, (Table 1) . Multinomial logistic regression, which can be used to analyse dichotomous which can be used to analyse dichotomous variables, was selected in preference to variables, was selected in preference to logistic regression for the analyses, because logistic regression for the analyses, because it has the advantage of calculating the it has the advantage of calculating the likelihood ratio test for each individual likelihood ratio test for each individual independent variable (Menard, 2001) . The independent variable (Menard, 2001) . The likelihood ratio test is useful for determinlikelihood ratio test is useful for determining the significance of variables included ing the significance of variables included in a logistic regression model. The odds in a logistic regression model. The odds ratios reported in Tables 4 and 5 The third analysis compared prevalence The third analysis compared prevalence estimates among individuals with and withestimates among individuals with and without psychosis in community population out psychosis in community population studies. Uncorrected odds ratios were calstudies. Uncorrected odds ratios were calculated for epidemiological studies using culated for epidemiological studies using data provided by the respective study data provided by the respective study authors. All analyses were performed using authors. All analyses were performed using the Statistical Package for the Social the Statistical Package for the Social Sciences, version 10. Sciences, version 10.
RESULTS RESULTS
Cannabis use and misuse Cannabis use and misuse prevalence estimates from prevalence estimates from treatment samples treatment samples Tables 2 and 3 display prevalences of curTables 2 and 3 display prevalences of current, 12-month and lifetime cannabis use rent, 12-month and lifetime cannabis use and misuse, respectively. Few studies have and misuse, respectively. Few studies have examined use and misuse in the same study. examined use and misuse in the same study. The average percentage of people using The average percentage of people using cannabis whose use was classified as 'miscannabis whose use was classified as 'misuse' was 42.9% for current use, 44.7% use' was 42.9% for current use, 44.7% for 12-month use and 53.5% for lifetime for 12-month use and 53.5% for lifetime use. Most studies reporting the prevalence use. Most studies reporting the prevalence of cannabis misuse did not distinguish of cannabis misuse did not distinguish between misuse and dependence (see between misuse and dependence (see Table 1 ). Of the four studies that provided Table 1 ). Of the four studies that provided data on misuse and dependence, three data on misuse and dependence, three reported that over 75% of those with reported that over 75% of those with cannabis misuse met the criteria for misuse, cannabis misuse met the criteria for misuse, rather than dependence. In contrast, the rather than dependence. In contrast, the fourth study reported that 78.6% of fourth study reported that 78.6% of patients with lifetime use and 68.0% of patients with lifetime use and 68.0% of those with current use were diagnosed with those with current use were diagnosed with dependence rather than misuse. The age dependence rather than misuse. The age and gender compositions of this latter study and gender compositions of this latter study and the other community-based study with and the other community-based study with misuse-dependence data were similar. misuse-dependence data were similar. However, the study diagnoses were However, the study diagnoses were based, respectively, on data collected by a based, respectively, on data collected by a trained research assistant who administered trained research assistant who administered the structured clinical interview for the structured clinical interview for DSM-III-R, DSM-III-R, and on ratings made by keyand on ratings made by keyworkers on scales based on DSM-IV workers on scales based on DSM-IV criteria. criteria.
Studies that used criteria from a standStudies that used criteria from a standardised classification system reported a ardised classification system reported a prevalence of 22.1% for lifetime misuse prevalence of 22.1% for lifetime misuse and 19.1% for 12-month misuse. The reand 19.1% for 12-month misuse. The respective prevalence rates for lifetime misuse spective prevalence rates for lifetime misuse and 12-month misuse reported by the and 12-month misuse reported by the studies that did not use criteria from a studies that did not use criteria from a standardised classification system were standardised classification system were 25.4% and 17.7%. All studies reporting 25.4% and 17.7%. All studies reporting current misuse had used criteria from a current misuse had used criteria from a standardised classification system (e.g. standardised classification system (e.g. DSM or ICD) to make this diagnosis. DSM or ICD) to make this diagnosis.
Prevalence estimates obtained Prevalence estimates obtained from urine testing of treatment from urine testing of treatment samples samples
The prevalence of cannabis use detected by The prevalence of cannabis use detected by urine testing was 12.3% (s.e.m. urine testing was 12.3% (s.e.m.¼0.9). This 0.9). This was based on a sample of 1460 pooled from was based on a sample of 1460 pooled from 12 studies. Information on the cut-off 12 studies. Information on the cut-off criteria used to determine the presence of criteria used to determine the presence of cannabinoids in urine was reported in only cannabinoids in urine was reported in only seven of the available studies. Criteria seven of the available studies. Criteria ranged from 20 ng/ml to 100 ng/ml. The ranged from 20 ng/ml to 100 ng/ml. The respective percentages of positive urine tests respective percentages of positive urine tests were 12.0% at 20 ng/ml (three studies), were 12.0% at 20 ng/ml (three studies), 31.4% at 35 ng/ml (one study), 14.6% at 31.4% at 35 ng/ml (one study), 14.6% at 3 0 8 3 0 8 AUTHOR'S PROOF AUTHOR'S PROOF 50 ng/ml (one study) and 10.0% at 100 ng/ 50 ng/ml (one study) and 10.0% at 100 ng/ ml (two studies). ml (two studies).
Multivariate analysis Multivariate analysis
The results of the multinomial logistic The results of the multinomial logistic regression are reported in Tables 4 and 5 . regression are reported in Tables 4 and 5 . Variables were initially entered in the Variables were initially entered in the following order: recruitment source, geofollowing order: recruitment source, geographic area, use of standardised substance graphic area, use of standardised substance misuse classification criteria, specificity of misuse classification criteria, specificity of diagnosis of psychosis, and first-episode diagnosis of psychosis, and first-episode status. Average age of the study samples, status. Average age of the study samples, percentage of males in a study and the medpercentage of males in a study and the median year of data collection for each study ian year of data collection for each study were covariates. The largest odds were conwere covariates. The largest odds were consistently associated with a broader diagsistently associated with a broader diagnosis of psychosis (e.g. psychosis or nosis of psychosis (e.g. psychosis or schizophrenia-spectrum disorder compared schizophrenia-spectrum disorder compared with schizophrenia). The significance levels with schizophrenia). The significance levels obtained for each of the four models indiobtained for each of the four models indicated that the independent variables signifcated that the independent variables significantly contributed to each model, but they icantly contributed to each model, but they were weak predictors as indicated by the were weak predictors as indicated by the Cannabis use and misuse Cannabis use and misuse prevalence in epidemiological prevalence in epidemiological studies studies Table 6 lists the prevalence estimates Table 6 lists the prevalence estimates obtained from epidemiological studies. All obtained from epidemiological studies. All 3 0 9 3 0 9 AUTHOR'S PROOF AUTHOR'S PROOF Tables 2 and 3.  estimates in Tables 2 and 3. The standard reference on cannabis The standard reference on cannabis misuse prevalence in the community among misuse prevalence in the community among people with schizophrenia is the Epidemiopeople with schizophrenia is the Epidemiologic Catchment Area study (Regier logic Catchment Area study (Regier et al et al, , 1990 
DISCUSSION DISCUSSION
A systematic review of published studies A systematic review of published studies found that the prevalence of misuse of canfound that the prevalence of misuse of cannabis was approximately half that of its nabis was approximately half that of its use, and that 12-month misuse prevalence use, and that 12-month misuse prevalence provided a sound indication of lifetime misprovided a sound indication of lifetime misuse prevalence. Current misuse prevalence use prevalence. Current misuse prevalence displayed the least variation across studies. displayed the least variation across studies. These estimates provide a benchmark to These estimates provide a benchmark to evaluate prevalence reported in subsequent evaluate prevalence reported in subsequent research, as well as to assist with decisions research, as well as to assist with decisions regarding the selection of appropriate preregarding the selection of appropriate prevalence intervals. The prevalence estimates valence intervals. The prevalence estimates were based on a total sample that was were based on a total sample that was larger than has previously been reported. larger than has previously been reported.
Study recruitment source Study recruitment source
We found no consistent pattern of inWe found no consistent pattern of increased or decreased odds associated with creased or decreased odds associated with recruitment source, although analysis of recruitment source, although analysis of epidemiological data indicated a consistent epidemiological data indicated a consistent pattern of increased odds of cannabis use pattern of increased odds of cannabis use and misuse associated with psychosis. Deand misuse associated with psychosis. Despite different study designs, the prevalence spite different study designs, the prevalence estimates obtained for people with psychoestimates obtained for people with psychosis from the epidemiological studies were sis from the epidemiological studies were consistently higher than the estimates for consistently higher than the estimates for non-psychosis samples. Although the low non-psychosis samples. Although the low lifetime prevalence use in the Swedish birth lifetime prevalence use in the Swedish birth cohort study (Zammit cohort study (Zammit et al et al, 2002) could be , 2002) could be attributed to the fact that the data were colattributed to the fact that the data were collected in 1969-70, the prevalence estimate lected in 1969-70, the prevalence estimate was similar to the Dutch household study was similar to the Dutch household study (van Os (van Os et al et al, 2002) which collected data , 2002) which collected data in 1996. The lifetime prevalence in the latin 1996. The lifetime prevalence in the latter study was almost half the current use ter study was almost half the current use prevalence reported in a population-based prevalence reported in a population-based first-incidence Dutch psychosis study (Veen first-incidence Dutch psychosis study (Veen et al et al, 2002) . Given that cannabis is readily , 2002). Given that cannabis is readily available in The Netherlands, the low lifeavailable in The Netherlands, the low lifetime prevalence reported in the epidemiotime prevalence reported in the epidemiological study supports the hypothesis that logical study supports the hypothesis that prevalence estimates may be inflated in prevalence estimates may be inflated in clinical samples. In contrast, the Australian clinical samples. In contrast, the Australian household study (Degenhardt & Hall, household study (Degenhardt & Hall, 2001 ) obtained 12-month prevalence esti-2001) obtained 12-month prevalence estimates similar to those reported in Tables  mates similar to those reported in Tables  2 and 3.  2 and 3. Epidemiological studies have important Epidemiological studies have important advantages over clinical samples in relation advantages over clinical samples in relation to sample size and representativeness; howto sample size and representativeness; however, with the exception of the Swedish ever, with the exception of the Swedish birth cohort study (Zammit birth cohort study (Zammit et al et al, 2002 (Zammit et al et al, ), , 2002 ), the number of people in the epidemiologithe number of people in the epidemiological studies with psychosis was relatively cal studies with psychosis was relatively small. Additionally, across the studies there small. Additionally, across the studies there was variation in the methods used and clinwas variation in the methods used and clinical experience of the researchers employed ical experience of the researchers employed to identify individuals with psychosis. to identify individuals with psychosis.
In relation to treatment samples, only In relation to treatment samples, only two studies provided prevalence estimates two studies provided prevalence estimates for samples from different sources (Soyka for samples from different sources (Soyka et al et al, 1993; Carr , 1993; Carr et al et al, 2002) . In the earlier , 2002). In the earlier study differences in the prevalence estistudy differences in the prevalence estimates might be accounted for by differmates might be accounted for by differences in admission criteria and functions ences in admission criteria and functions of the hospitals, and the fact that the uniof the hospitals, and the fact that the university sample had a significantly lower versity sample had a significantly lower percentage of males -indeed, the lowest percentage of males -indeed, the lowest percentage of males of any study reviewed. percentage of males of any study reviewed.
Diagnostic criteria and data Diagnostic criteria and data collection collection
The most consistent finding across the mulThe most consistent finding across the multivariate analyses was the increased odds tivariate analyses was the increased odds associated with a broader diagnosis (e.g. associated with a broader diagnosis (e.g. psychosis compared with schizophrenia). psychosis compared with schizophrenia). This suggests that a fundamental criterion This suggests that a fundamental criterion for inclusion in a study might account for for inclusion in a study might account for some of the variation in prevalence estisome of the variation in prevalence estimates. One explanation for the increased mates. One explanation for the increased odds associated with the broader diagnosis odds associated with the broader diagnosis of psychosis is the possible inclusion of of psychosis is the possible inclusion of individuals with drug-induced psychoses. individuals with drug-induced psychoses.
The criteria for diagnosing substance The criteria for diagnosing substance misuse could only be examined for lifetime misuse could only be examined for lifetime misuse, as all studies of current misuse had misuse, as all studies of current misuse had adopted some form of standardised criteria. adopted some form of standardised criteria. It was originally intended to examine preIt was originally intended to examine prevalence in terms of the method used to valence in terms of the method used to diagnose substance misuse; however, the diagnose substance misuse; however, the diversity of approaches in reviewed studies diversity of approaches in reviewed studies (e.g. the use of some questions from struc-(e.g. the use of some questions from structured interviews within clinical interviews) tured interviews within clinical interviews) made categorising studies using this made categorising studies using this criterion problematic. criterion problematic.
Differences in prevalence have been Differences in prevalence have been accounted for by both criteria and inforaccounted for by both criteria and information variance (Klerman, 1985) . The mation variance (Klerman, 1985) . The importance of considering the criteria importance of considering the criteria used comes from a study that compared used comes from a study that compared substance use diagnoses in a first-episode substance use diagnoses in a first-episode patient sample made by a research team patient sample made by a research team with those made by clinicians. The research with those made by clinicians. The research team and clinicians diagnosed cannabis use team and clinicians diagnosed cannabis use disorder in 8.5% and 33.3% of the patients disorder in 8.5% and 33.3% of the patients respectively. Generally, disagreement was respectively. Generally, disagreement was attributed to differences in applying diagattributed to differences in applying diagnostic criteria rather than differences in nostic criteria rather than differences in the information that was available (Fennig the information that was available (Fennig et al et al, 1996) . In contrast, the differences in , 1996). In contrast, the differences in prevalence estimates reported in the Epiprevalence estimates reported in the Epidemiologic Catchment Area and National demiologic Catchment Area and National Comorbidity Survey studies have been Comorbidity Survey studies have been attributed to information variance (Regier attributed to information variance (Regier et al et al, 1998; Narrow , 1998; Narrow et al et al, 2002) . This infor-, 2002) . This information variance was considered to be due mation variance was considered to be due to differences in the nature of interviews to differences in the nature of interviews that were employed. that were employed.
Study design has also been reported to Study design has also been reported to affect disclosure of sensitive information affect disclosure of sensitive information (Kessler (Kessler et al et al, 2000) . Inconsistencies in , 2000). Inconsistencies in reporting have been found to be greater reporting have been found to be greater among people using cocaine compared with among people using cocaine compared with those using cannabis, with inconsistent those using cannabis, with inconsistent accounts of lifetime use more likely by accounts of lifetime use more likely by people with lower levels of use (Fendrich people with lower levels of use (Fendrich & Mackesy Amiti, 1995) . Although the & Mackesy Amiti, 1995) . Although the presence of underreporting can be difficult presence of underreporting can be difficult to determine, patient self-report has been to determine, patient self-report has been found to accord with urine tests (Fowler found to accord with urine tests (Fowler et al et al, 1998) and collateral sources (Carey , 1998) and collateral sources (Carey & Simons, 2000) . However, a study by & Simons, 2000). However, a study by Swartz Swartz et al et al (2003) found that cannabis (2003) found that cannabis prevalence differed according to the methprevalence differed according to the method of data collection: self-report od of data collection: self-report 9.4%, 9.4%, urine testing 6.4% and hair analysis urine testing 6.4% and hair analysis 19.9%. The prevalence obtained by hair 19.9%. The prevalence obtained by hair analysis is closest to the current use analysis is closest to the current use reported in Table 2 . reported in Table 2 .
Prevalence estimates obtained by urine Prevalence estimates obtained by urine testing raise two issues of interest. First, testing raise two issues of interest. First, prevalence was not markedly lower when prevalence was not markedly lower when a higher cut-off criterion was used. Second, a higher cut-off criterion was used. Second, some studies noted that patients who resome studies noted that patients who reported cannabis use did not return a posiported cannabis use did not return a positive result (Condren tive result (Condren et al et al, 2001) . A similar , 2001). A similar finding has been reported in relation to hair finding has been reported in relation to hair analysis (Selten analysis (Selten et al et al, 2002) . A factor , 2002). A factor accounting for the former finding and difaccounting for the former finding and differences in prevalence is likely to be the ferences in prevalence is likely to be the frequency of cannabis use and the time infrequency of cannabis use and the time interval from use to testing. At the 20 ng/ml terval from use to testing. At the 20 ng/ml cut-off level, infrequent cannabis users cut-off level, infrequent cannabis users 31 0 31 0 AUTHOR'S PROOF AUTHOR'S PROOF would on average be expected to test posiwould on average be expected to test positive 2-3 days after cannabis use, whereas tive 2-3 days after cannabis use, whereas frequent users would on average test frequent users would on average test positive for 9-12 days (Kelly & Jones, positive for 9-12 days (Kelly & Jones, 1992) . Information on when testing was 1992). Information on when testing was conducted (e.g. average days after conducted (e.g. average days after admission), method of testing and cut-off admission), method of testing and cut-off criteria employed are necessary to evaluate criteria employed are necessary to evaluate more fully cannabis prevalence data based more fully cannabis prevalence data based on urine testing. on urine testing.
Age and gender Age and gender
Age was associated with slightly increased Age was associated with slightly increased odds of misuse (current and lifetime) and odds of misuse (current and lifetime) and decreased odds of use (current and lifedecreased odds of use (current and lifetime); higher percentages of males in a time); higher percentages of males in a study sample were associated with a small study sample were associated with a small increase in odds of use and misuse across increase in odds of use and misuse across the prevalence intervals. Although two the prevalence intervals. Although two studies were identified that did not find difstudies were identified that did not find differences in either age or gender between ferences in either age or gender between those using cannabis and other patients those using cannabis and other patients (Peralta & Cuesta, 1992; Sembhi & Lee, (Peralta & Cuesta, 1992; Sembhi & Lee, 1999) , a number of studies have found 1999), a number of studies have found that cannabis use and misuse are associated that cannabis use and misuse are associated with younger age (Mueser with younger age (Mueser et al et al, 1990 (Mueser et al et al, , , 1990 (Mueser et al et al, , 2000 (Mueser et al et al, 1990 , 1992 , 2000 Mathers , 1990 Mathers , , 1992 Mathers , , 2000 Mathers et al et al, 1991; Negrete & Gill, 1999; Nunez , 1991; Negrete & Gill, 1999; Nú ñ ez & Gurpegui, 2002; Veen & Gurpegui, 2002; Veen et al et al, 2002) . The , 2002). The findings from our review also suggest that findings from our review also suggest that the age and gender composition of study the age and gender composition of study samples would be expected to contribute samples would be expected to contribute to variation in prevalence estimates across to variation in prevalence estimates across studies. studies.
Year of data collection Year of data collection
No consistent association was found beNo consistent association was found between prevalence and median year of data tween prevalence and median year of data collection. A review by Cuffel (1992) collection. A review by Cuffel (1992) reported an association between the year reported an association between the year of data collection and alcohol or amphetaof data collection and alcohol or amphetamine use; in that review, more recent mine use; in that review, more recent studies reported higher prevalence. The studies reported higher prevalence. The studies included by Cuffel were from the studies included by Cuffel were from the period 1960-1991 and there were inperiod 1960-1991 and there were insufficient studies on cannabis to examine sufficient studies on cannabis to examine this relationship. Our review included this relationship. Our review included studies published between 1990 and 2002, studies published between 1990 and 2002, which collected data between 1983 and which collected data between 1983 and 2002. It may be the case that more time is 2002. It may be the case that more time is required to determine a temporal pattern, required to determine a temporal pattern, or that other factors may interact with time or that other factors may interact with time period, such as changes in cannabis period, such as changes in cannabis availability.
availability.
An illustration of how prevalence estiAn illustration of how prevalence estimates vary over time is illustrated by two mates vary over time is illustrated by two US studies. The first study, which collected US studies. The first study, which collected data between 1983 and 1986 (Mueser data between 1983 and 1986 (Mueser et al et al, , 1990 , reported a 40% lifetime prevalence 1990), reported a 40% lifetime prevalence of cannabis use. A subsequent study from of cannabis use. A subsequent study from the same area (Mueser the same area (Mueser et al et al, 1992 (Mueser et al et al, ) that , 1992 that collected data between 1986 and 1990 collected data between 1986 and 1990 reported a lifetime prevalence of 15.7%. reported a lifetime prevalence of 15.7%. These findings need to be considered in These findings need to be considered in the context of the decreasing use of cannathe context of the decreasing use of cannabis reported in the USA in the 1980s and bis reported in the USA in the 1980s and the increased use of cocaine in the same the increased use of cocaine in the same period (Costa e Silva, 2002). period (Costa e Silva, 2002).
Geographic area Geographic area
No consistent association was found beNo consistent association was found between prevalence of use or misuse and geotween prevalence of use or misuse and geographic area. Where prevalence estimates graphic area. Where prevalence estimates vary by geographic area this may be due vary by geographic area this may be due to factors such as drug availability or to factors such as drug availability or changing trends in drug preference, as changing trends in drug preference, as well as preferences for different research well as preferences for different research designs. designs.
Limitations of our study Limitations of our study
A limitation of our review is that studies of A limitation of our review is that studies of varying methodologies and methodological varying methodologies and methodological rigour were combined. The impact of difrigour were combined. The impact of different methods on prevalence estimates is ferent methods on prevalence estimates is difficult to determine and requires further difficult to determine and requires further attention; the issue of study quality was attention; the issue of study quality was addressed by only including studies that addressed by only including studies that met the inclusion criteria, especially the remet the inclusion criteria, especially the requirement that adequate detail was availquirement that adequate detail was available. Pooling studies from different able. Pooling studies from different countries and time periods may have been countries and time periods may have been problematic; however, these variables were problematic; however, these variables were included in the logistic regression and speciincluded in the logistic regression and specific prevalence estimates for these variables fic prevalence estimates for these variables were provided separately. were provided separately.
Future research Future research
This review produced cannabis prevalence This review produced cannabis prevalence estimates based on the most comprehensive estimates based on the most comprehensive data to date and systematically examined data to date and systematically examined factors that might account for the variation factors that might account for the variation in prevalence estimates across studies. The in prevalence estimates across studies. The increased odds of cannabis use and misuse increased odds of cannabis use and misuse among the population-based studies supamong the population-based studies supports the view that the high prevalence ports the view that the high prevalence rates in treatment samples are not simply rates in treatment samples are not simply a sampling artefact. Among the treatment a sampling artefact. Among the treatment samples, specificity of the diagnosis of psysamples, specificity of the diagnosis of psychosis was the variable most consistently chosis was the variable most consistently associated with increased odds of cannabis associated with increased odds of cannabis use or misuse. The percentage of male paruse or misuse. The percentage of male participants in the study samples was assoticipants in the study samples was associated with a small increase in odds of use ciated with a small increase in odds of use and misuse, whereas age was associated and misuse, whereas age was associated with increased odds of misuse and with increased odds of misuse and decreased odds of use. This was the one decreased odds of use. This was the one consistent difference between the use and consistent difference between the use and misuse models. As the majority of variance misuse models. As the majority of variance in predicting use and misuse was not acin predicting use and misuse was not accounted for by the common methodological counted for by the common methodological variables included in this review, a more variables included in this review, a more finely grained examination of the impact finely grained examination of the impact of different data collection tools is required. of different data collection tools is required. It will be important to examine additional It will be important to examine additional factors such as motivation, disorder severfactors such as motivation, disorder severity, craving and consumption levels, which ity, craving and consumption levels, which might account for continued cannabis use might account for continued cannabis use and misuse. Such research has both clinical and misuse. Such research has both clinical and policy implications, particularly in and policy implications, particularly in countries with high prevalence estimates. countries with high prevalence estimates. Least variability in prevalence estimates was found when current misuse was diagnosed using a standardised assessment approach. diagnosed using a standardised assessment approach.
& & For urine testing to be an effective means of determining current use, issues such For urine testing to be an effective means of determining current use, issues such as the interval between use and testing, cut-off levels and method need to be as the interval between use and testing, cut-off levels and method need to be considered. considered. & & A more fine-grained approach to examining how data collection differed across A more fine-grained approach to examining how data collection differed across studies was not undertaken. studies was not undertaken.
LIMITATIONS LIMITATIONS
